Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment

NCT01747538 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

281

Enrollment

INDUSTRY

Sponsor class

Conditions

Uveitis

Interventions

DRUG: Placebo
DRUG: Dose 1 gevokizumab
DRUG: Dose 2 gevokizumab

Sponsor

XOMA (US) LLC

Collaborators

[object Object]